Both androgen and androgen receptor (AR) play a crucial role in the development and progression of PCa, and androgen deprivation therapy is typically employed as a first-line treatment for PCa patients to impede the AR signaling in metastasis PCa [3,4]. This evidence concerns the gene AR and posterior cortical atrophy.